Fingerprint
Dive into the research topics of 'Mutant KRAS is a druggable target for pancreatic cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Mutant KRAS is a druggable target for pancreatic cancer
Elina Zorde Khvalevsky, Racheli Gabai, Itzhak Haim Rachmut, Elad Horwitz, Zivia Brunschwig, Ariel Orbach, Adva Shemi, Talia Golan, Abraham J. Domb, Eylon Yavin, Hilla Giladi, Ludmila Rivkin, Alina Simerzin, Rami Eliakim, Abed Khalaileh, Ayala Hubert, Maor Lahav, Yael Kopelman, Eran Goldin, Alan Dancour
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
248
Scopus
citations